Reduction in QT dispersion by sotalol following myocardial infarction
- PMID: 2040324
- DOI: 10.1093/oxfordjournals.eurheartj.a059911
Reduction in QT dispersion by sotalol following myocardial infarction
Abstract
Increased dispersion of ventricular recovery time is believed to be a substrate for serious ventricular arrhythmias. Class III antiarrhythmic drugs probably operate by decreasing dispersion through homogeneous prolongation of recovery time. A single surface QT value gives no information on recovery time dispersion but interlead variation in QT may be relevant. QTc dispersion was measured in 67 patients post myocardial infarction randomized to treatment with either sotalol or placebo. QTc dispersion was calculated as the difference between the maximum and minimum QTc in any surface electrocardiogram lead. Both maximum QTc and QTc dispersion varied considerably following infarction but throughout the 6-month follow-up period maximum QTc was significantly greater (P less than 0.05) and QTc dispersion significantly less (P less than 0.05) in patients on sotalol compared with placebo. These findings are in accord with expected changes in ventricular recovery time and provide strong support for the hypothesis that surface electrocardiogram QT variation reflects regional differences in ventricular recovery time.
Similar articles
-
QT dispersion: an indication of arrhythmia risk in patients with long QT intervals.Br Heart J. 1990 Jun;63(6):342-4. doi: 10.1136/hrt.63.6.342. Br Heart J. 1990. PMID: 2375895 Free PMC article.
-
Repolarization changes in a double-blind crossover study of dofetilide versus sotalol in the treatment of ventricular tachycardia.Pacing Clin Electrophysiol. 2000 Nov;23(11 Pt 2):1935-8. doi: 10.1111/j.1540-8159.2000.tb07056.x. Pacing Clin Electrophysiol. 2000. PMID: 11139961 Clinical Trial.
-
QT dispersion and early arrhythmic risk during acute myocardial infarction.Angiology. 1999 Mar;50(3):209-15. doi: 10.1177/000331979905000305. Angiology. 1999. PMID: 10088800
-
Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol.Drugs. 1995 May;49(5):664-79. doi: 10.2165/00003495-199549050-00003. Drugs. 1995. PMID: 7601009 Review.
-
Sotalol.N Engl J Med. 1994 Jul 7;331(1):31-8. doi: 10.1056/NEJM199407073310108. N Engl J Med. 1994. PMID: 8202100 Review.
Cited by
-
ECG Changes in Melanoma Patients Undergoing Cancer Therapy-Data From the ECoR Registry.J Clin Med. 2020 Jun 30;9(7):2060. doi: 10.3390/jcm9072060. J Clin Med. 2020. PMID: 32630003 Free PMC article.
-
Ventricular repolarization, T-wave genesis, and risk prediction.Ann Noninvasive Electrocardiol. 2001 Jan;6(1):1-4. doi: 10.1111/j.1542-474x.2001.tb00079.x. Ann Noninvasive Electrocardiol. 2001. PMID: 11174856 Free PMC article. No abstract available.
-
QT interval in patients with unstable angina and non-Q wave myocardial infarction.Ann Noninvasive Electrocardiol. 2002 Oct;7(4):343-8. doi: 10.1111/j.1542-474x.2002.tb00183.x. Ann Noninvasive Electrocardiol. 2002. PMID: 12431312 Free PMC article.
-
Enhanced detection of ischemic but viable myocardium by QT interval dispersion on treadmill exercise electrocardiograms of patients with healed anterior wall myocardial infarcts.Clin Cardiol. 2000 Apr;23(4):277-84. doi: 10.1002/clc.4960230411. Clin Cardiol. 2000. PMID: 10763076 Free PMC article.
-
QTc dispersion and risk of cardiac death in peripheral vascular disease. Dispersion of 60 ms1/2 is insufficient to change clinical management.BMJ. 1996 Oct 26;313(7064):1081, author reply 1082-3. doi: 10.1136/bmj.313.7064.1081c. BMJ. 1996. PMID: 8898617 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical